# PAPSS1

## Overview
PAPSS1, or 3'-phosphoadenosine 5'-phosphosulfate synthase 1, is a gene that encodes a bifunctional enzyme crucial for the synthesis of 3'-phosphoadenosine 5'-phosphosulfate (PAPS), the primary sulfate donor in humans. This enzyme plays a vital role in various sulfation reactions, which are essential for modifying proteins, lipids, and carbohydrates, thereby influencing processes such as detoxification, hormone regulation, and tissue integrity. The PAPSS1 enzyme is characterized by its two main domains: the N-terminal APS kinase domain and the C-terminal ATP sulfurylase domain, which together facilitate the conversion of inorganic sulfate to PAPS. This enzyme is predominantly localized in the nucleus, where it participates in nuclear-cytoplasmic transport processes, and is involved in the biosynthesis of heparan sulfate, a critical component for viral attachment and infection. PAPSS1's interactions with other proteins, such as DHEA sulfotransferase SULT2A1 and estrogen receptor alpha, underscore its multifaceted role in cellular processes and its potential as a therapeutic target in cancer treatment (Schröder2012Human; Suzuki2022Genomewide; Sun2023The).

## Structure
PAPSS1 is a bifunctional enzyme composed of two main domains: the N-terminal APS kinase domain and the C-terminal ATP sulfurylase domain. The APS kinase domain is responsible for phosphorylating adenosine-5'-phosphosulfate (APS) to produce 3'-phosphoadenosine 5'-phosphosulfate (PAPS), while the ATP sulfurylase domain catalyzes the formation of APS from inorganic sulfate and ATP (Sekulic2007Elucidation; Venkatachalam2003Human).

The enzyme's bifunctionality is a result of evolutionary gene fusion, combining these two domains, which are separate in other organisms (Venkatachalam2003Human). The APS kinase domain forms symmetrical dimers and adopts a fold consistent with the full-length PAPSS1 enzyme (Sekulic2007Elucidation). The presence of magnesium ions is crucial for the proper conformation of the DGDN-loop, which is essential for enzyme activity (Sekulic2007Elucidation).

PAPSS1 may exhibit a Rossmann fold, common in nucleotide-binding proteins, and can undergo post-translational modifications such as phosphorylation. The enzyme can exist in different isoforms due to alternative splicing, which may affect its kinetic behavior and tissue-specific expression (Schröder2012Human; Venkatachalam2003Human). The linker region between the domains might play a role in structural stabilization rather than catalytic efficiency (Venkatachalam2003Human).

## Function
PAPSS1 encodes the enzyme 3'-phosphoadenosine 5'-phosphosulfate synthase 1, which is essential for the synthesis of 3'-phosphoadenosine 5'-phosphosulfate (PAPS), the sole sulfate donor in humans. This enzyme is crucial for various sulfation reactions, which are important for modifying proteins, lipids, and carbohydrates. These modifications play significant roles in cellular processes such as detoxification, hormone regulation, and maintaining the structural integrity of tissues (Schröder2012Human).

PAPSS1 is involved in the biosynthesis of heparan sulfate (HepS), a linear polysaccharide that is critical for viral attachment to host cells. In cells where PAPSS2 is not expressed or is less active, PAPSS1 plays a key role in HepS biosynthesis, which is important for viral binding and infection processes (Suzuki2022Genomewide).

The enzyme is active in both the cytoplasm and nucleus, with its localization influenced by specific motifs. PAPSS1 predominantly localizes in the nucleus, facilitated by a strong nuclear localization signal (NLS), and is involved in nuclear-cytoplasmic transport processes (Schröder2012Human). This dynamic regulation and localization suggest that PAPSS1 has distinct roles in different cellular compartments, contributing to its diverse functions in healthy human cells.

## Clinical Significance
Alterations in the expression of the PAPSS1 gene have been implicated in various cancers, affecting both disease progression and treatment response. In hepatocellular carcinoma (HCC), genetic variations in PAPSS1 are associated with increased risk, particularly in hepatitis B virus carriers. Specific haplotypes, such as C-T-T, are linked to elevated serum alpha-fetoprotein levels and poorer survival outcomes in familial HCC cases, although they do not correlate with tumor size or number of lesions (Shih2009Evidence).

In non-small cell lung cancer (NSCLC) and ovarian cancer, PAPSS1 expression levels influence sensitivity to cisplatin, a common chemotherapy drug. Low PAPSS1 expression in NSCLC is associated with increased sensitivity to cisplatin and improved survival outcomes following platinum-based chemotherapy (Leung2017In). In ovarian cancer, high PAPSS1 expression correlates with cisplatin resistance, while its silencing enhances drug sensitivity by promoting apoptosis and affecting DNA repair mechanisms. This suggests that PAPSS1 could serve as a therapeutic target to improve chemotherapy efficacy (Sun2023The).

These findings highlight the potential of PAPSS1 as a biomarker for cancer prognosis and treatment response, particularly in the context of platinum-based therapies.

## Interactions
PAPSS1 (3'-phosphoadenosine 5'-phosphosulfate synthase 1) is involved in several protein interactions that are crucial for its function in sulfation processes. It interacts with DHEA sulfotransferase SULT2A1, which is essential for DHEA sulfation. This interaction is part of a multiprotein complex necessary for the sulfation pathway, as demonstrated by proximity ligation assays in HepG2 cells (Mueller2018Human). 

PAPSS1 also plays a role in modulating the response to cisplatin in ovarian cancer cells by regulating estrogen receptor alpha (ERα) signaling. The study by Sun et al. suggests a potential interaction between PAPSS1 and ERα, indicating that ERα might be a PAPSS1-binding partner in ovarian cancer cells (Sun2023The). 

In the context of viral infections, PAPSS1 is involved in the biosynthesis of heparan sulfate (HepS), a process critical for HSV-1 infection. The enzyme's role in HepS synthesis highlights its importance in the sulfation process, which is essential for viral attachment and entry (Suzuki2022Genomewide). These interactions underscore the multifaceted role of PAPSS1 in cellular processes and its potential as a therapeutic target.


## References


[1. (Sekulic2007Elucidation) Nikolina Sekulic, Kristen Dietrich, Ingo Paarmann, Stephan Ort, Manfred Konrad, and Arnon Lavie. Elucidation of the active conformation of the aps-kinase domain of human paps synthetase 1. Journal of Molecular Biology, 367(2):488–500, March 2007. URL: http://dx.doi.org/10.1016/j.jmb.2007.01.025, doi:10.1016/j.jmb.2007.01.025. This article has 31 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2007.01.025)

[2. (Sun2023The) Lei Sun, Wei-Xue Ji, Yan Li, Ze-Lian Li, Can-Can Duan, Bai-rong Xia, and Lan Xiao. The papss1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells. Journal of Ovarian Research, September 2023. URL: http://dx.doi.org/10.1186/s13048-023-01262-7, doi:10.1186/s13048-023-01262-7. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13048-023-01262-7)

[3. (Leung2017In) Ada W.Y. Leung, Chansey J. Veinotte, Nicole Melong, Min Hee Oh, Kent Chen, Katey S.S. Enfield, Ian Backstrom, Corinna Warburton, Donald Yapp, Jason N. Berman, Marcel B. Bally, and William W. Lockwood. In vivo validation of papss1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a cisplatin-sensitizing therapeutic target. Clinical Cancer Research, 23(21):6555–6566, October 2017. URL: http://dx.doi.org/10.1158/1078-0432.ccr-17-0700, doi:10.1158/1078-0432.ccr-17-0700. This article has 12 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/1078-0432.ccr-17-0700)

[4. (Suzuki2022Genomewide) Takeshi Suzuki, Yoshitaka Sato, Yusuke Okuno, Fumi Goshima, Tadahisa Mikami, Miki Umeda, Takayuki Murata, Takahiro Watanabe, Koichi Watashi, Takaji Wakita, Hiroshi Kitagawa, and Hiroshi Kimura. Genome-wide crispr screen for hsv-1 host factors reveals papss1 contributes to heparan sulfate synthesis. Communications Biology, July 2022. URL: http://dx.doi.org/10.1038/s42003-022-03581-9, doi:10.1038/s42003-022-03581-9. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-022-03581-9)

[5. (Shih2009Evidence) Wei-Liang Shih, Ming-Whei Yu, Pei-Jer Chen, Tai-Wei Wu, Chih-Lin Lin, Chun-Jen Liu, Shi-Ming Lin, Dar-In Tai, Shou-Dong Lee, and Yun-Fan Liaw. Evidence for association with hepatocellular carcinoma at the papss1 locus on chromosome 4q25 in a family-based study. European Journal of Human Genetics, 17(10):1250–1259, April 2009. URL: http://dx.doi.org/10.1038/ejhg.2009.48, doi:10.1038/ejhg.2009.48. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2009.48)

[6. (Mueller2018Human) Jonathan W. Mueller, Jan Idkowiak, Tarsis F. Gesteira, Cecilia Vallet, Rebecca Hardman, Johannes van den Boom, Vivek Dhir, Shirley K. Knauer, Edina Rosta, and Wiebke Arlt. Human dhea sulfation requires direct interaction between paps synthase 2 and dhea sulfotransferase sult2a1. Journal of Biological Chemistry, 293(25):9724–9735, June 2018. URL: http://dx.doi.org/10.1074/jbc.ra118.002248, doi:10.1074/jbc.ra118.002248. This article has 29 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra118.002248)

[7. (Schröder2012Human) Elisabeth Schröder, Lena Gebel, Andrey A. Eremeev, Jessica Morgner, Daniel Grum, Shirley K. Knauer, Peter Bayer, and Jonathan W. Mueller. Human paps synthase isoforms are dynamically regulated enzymes with access to nucleus and cytoplasm. PLoS ONE, 7(1):e29559, January 2012. URL: http://dx.doi.org/10.1371/journal.pone.0029559, doi:10.1371/journal.pone.0029559. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0029559)

[8. (Venkatachalam2003Human) KV Venkatachalam. Human 3’‐phosphoadenosine 5’‐phosphosulfate (paps) synthase: biochemistry, molecular biology and genetic deficiency. IUBMB Life, 55(1):1–11, January 2003. URL: http://dx.doi.org/10.1080/1521654031000072148, doi:10.1080/1521654031000072148. This article has 87 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/1521654031000072148)